|
|
Previous Article | Table of Contents | Next Article 
In Vitro Regulation of Fc RI Expression on Human Basophils by
IgE Antibody
Donald MacGlashan Jr,
Jane McKenzie-White,
Kristine Chichester,
Bruce S. Bochner,
Frances M. Davis,
John T. Schroeder, and
Lawrence
M. Lichtenstein
From the Johns Hopkins Asthma and Allergy Center, Baltimore, MD; and
Tanox Biosystems, Inc, Houston, TX.
In vivo studies suggested the possibility of an IgE-dependent
regulation of high-affinity (Fc RI) IgE receptor expression on
basophils. The current studies extend these observations to in vitro
cultures of human basophils. Incubation of basophils for 3 to 4 weeks
resulted in a slow dissociation of IgE antibody, during which time
Fc RI expression decreased, as measured by flow cytometry using the
anti-Fc RI monoclonal antibody, 22E7, or by measuring Fc RI
mass by Western blotting of whole-cell lysates. Culture of basophils
with IgE resulted in upregulation of Fc RI expression by both flow
cytometry and Western blotting of whole-cell lysates. Upregulation
followed a linear time course during 2 weeks of culture. The relative
increase in Fc RI density depended on the starting density; with
starting densities of Fc RI of 10,000 to 170,000 per basophil, the
upregulation varied 20- to 1.1-fold, respectively. Upregulation
occurred in high-purity basophils, was not influenced by IgG at
concentrations up to 1 mg/mL, and was inhibited by dimeric IgE.
Heat-inactivated IgE was less effective and the monoclonal antibody
CGP51901 that prevents IgE binding to Fc RI blocked the ability of
IgE to induce upregulation. The dose-response curve for IgE-induced
upregulation had an effective concentration50 of 230 ng/mL.
Although the receptor through which IgE induces this upregulation is
not yet known, several characteristics suggest that the upregulation is
mediated by IgE interacting through Fc RI itself.
Blood, Vol. 91 No. 5 (March 1), 1998:
pp. 1633-1643
© 1998 by The American Society of Hematology.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. W. MacGlashan Jr.
Endocytosis, recycling, and degradation of unoccupied Fc{epsilon}RI in human basophils
J. Leukoc. Biol.,
October 1, 2007;
82(4):
1003 - 1010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Hendeles and C. A Sorkness
Anti-Immunoglobulin E Therapy with Omalizumab for Asthma
Ann. Pharmacother.,
September 1, 2007;
41(9):
1397 - 1410.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Gomez, S. Jogie-Brahim, M. Shima, and L. B. Schwartz
Omalizumab Reverses the Phenotypic and Functional Effects of IgE-Enhanced Fc{epsilon}RI on Human Skin Mast Cells
J. Immunol.,
July 15, 2007;
179(2):
1353 - 1361.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Demarest, J. Hopp, J. Chung, K. Hathaway, E. Mertsching, X. Cao, J. George, K. Miatkowski, M. J. LaBarre, M. Shields, et al.
An Intermediate pH Unfolding Transition Abrogates the Ability of IgE to Interact with Its High Affinity Receptor Fc{epsilon}RI{alpha}
J. Biol. Chem.,
October 13, 2006;
281(41):
30755 - 30767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Gounni
The high-affinity IgE receptor (Fc{epsilon}RI): a critical regulator of airway smooth muscle cells?
Am J Physiol Lung Cell Mol Physiol,
September 1, 2006;
291(3):
L312 - L321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Schroeder, A. P. Bieneman, H. Xiao, K. L. Chichester, K. Vasagar, S. Saini, and M. C. Liu
TLR9- and Fc{epsilon}RI-Mediated Responses Oppose One Another in Plasmacytoid Dendritic Cells by Down-Regulating Receptor Expression
J. Immunol.,
November 1, 2005;
175(9):
5724 - 5731.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Gounni, V. Wellemans, J. Yang, F. Bellesort, K. Kassiri, S. Gangloff, M. Guenounou, A. J. Halayko, Q. Hamid, and B. Lamkhioued
Human Airway Smooth Muscle Cells Express the High Affinity Receptor for IgE (Fc{epsilon}RI): A Critical Role of Fc{epsilon}RI in Human Airway Smooth Muscle Cell Function
J. Immunol.,
August 15, 2005;
175(4):
2613 - 2621.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Y.M. Leung, H. A. Sampson, J. W. Yunginger, A. W. Burks Jr., L. C. Schneider, C. H. Wortel, F. M. Davis, J. D. Hyun, W. R. Shanahan Jr., and the TNX-901 Peanut Allergy Study Group
Effect of Anti-IgE Therapy in Patients with Peanut Allergy
N. Engl. J. Med.,
March 13, 2003;
348(11):
986 - 993.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kubo, T. Nakayama, K. Matsuoka, H. Yonekawa, and H. Karasuyama
Long Term Maintenance of IgE-Mediated Memory in Mast Cells in the Absence of Detectable Serum IgE
J. Immunol.,
January 15, 2003;
170(2):
775 - 780.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Arock, E. Schneider, M. Boissan, V. Tricottet, and M. Dy
Differentiation of human basophils: an overview of recent advances and pending questions
J. Leukoc. Biol.,
April 1, 2002;
71(4):
557 - 564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kubo, K. Matsuoka, C. Taya, F. Kitamura, T. Takai, H. Yonekawa, and H. Karasuyama
Drastic Up-Regulation of Fc{epsilon}RI on Mast Cells Is Induced by IgE Binding Through Stabilization and Accumulation of Fc{epsilon}RI on the Cell Surface
J. Immunol.,
September 15, 2001;
167(6):
3427 - 3434.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Miura, S. S. Saini, G. Gauvreau, and D. W. MacGlashan Jr
Differences in Functional Consequences and Signal Transduction Induced by IL-3, IL-5, and Nerve Growth Factor in Human Basophils
J. Immunol.,
August 15, 2001;
167(4):
2282 - 2291.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. MacGlashan Jr., H.-Z. Xia, L. B. Schwartz, and J. Gong
IgE-regulated loss, not IgE-regulated synthesis, controls expression of Fc{varepsilon}RI in human basophils
J. Leukoc. Biol.,
August 1, 2001;
70(2):
207 - 218.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Borkowski, M.-H. Jouvin, S.-Y. Lin, and J.-P. Kinet
Minimal Requirements for IgE-Mediated Regulation of Surface Fc{epsilon}RI
J. Immunol.,
August 1, 2001;
167(3):
1290 - 1296.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kambe, M. Kambe, J. P. Kochan, and L. B. Schwartz
Human skin-derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes
Blood,
April 1, 2001;
97(7):
2045 - 2052.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. H. Falcone, H. Haas, and B. F. Gibbs
The human basophil: a new appreciation of its role in immune responses
Blood,
December 15, 2000;
96(13):
4028 - 4038.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Albrecht, M. Woisetschlager, and M. W. Robertson
Export of the High Affinity IgE Receptor From the Endoplasmic Reticulum Depends on a Glycosylation-Mediated Quality Control Mechanism
J. Immunol.,
November 15, 2000;
165(10):
5686 - 5694.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. MacGlashan Jr and J. T. Schroeder
Functional consequences of Fc{varepsilon}RI{alpha} up-regulation by IgE in human basophils
J. Leukoc. Biol.,
October 1, 2000;
68(4):
479 - 486.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. Bheekha-Escura, D. W. MacGlashan Jr, J. M. Langdon, and S. M. MacDonald
Human recombinant histamine-releasing factor activates human eosinophils and the eosinophilic cell line, AML14-3D10
Blood,
September 15, 2000;
96(6):
2191 - 2198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. HIZAWA, E. YAMAGUCHI, E. JINUSHI, and Y. KAWAKAMI
A Common FCER1B Gene Promoter Polymorphism* Influences Total Serum IgE Levels in a Japanese Population
Am. J. Respir. Crit. Care Med.,
March 1, 2000;
161(3):
906 - 909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-C. Seminario, S. S. Saini, D. W. MacGlashan Jr., and B. S. Bochner
Intracellular Expression and Release of Fc{epsilon}RI{alpha} by Human Eosinophils
J. Immunol.,
June 1, 1999;
162(11):
6893 - 6900.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Saini, D. W. MacGlashan Jr., S. A. Sterbinsky, A. Togias, D. C. Adelman, L. M. Lichtenstein, and B. S. Bochner
Down-Regulation of Human Basophil IgE and FC{epsilon}RI{alpha} Surface Densities and Mediator Release by Anti-IgE-Infusions Is Reversible In Vitro and In Vivo
J. Immunol.,
May 1, 1999;
162(9):
5624 - 5630.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Huber, C. D. Helgason, J. E. Damen, L. Liu, R. K. Humphries, and G. Krystal
The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation
PNAS,
September 15, 1998;
95(19):
11330 - 11335.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |